HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression - Quiz - MDSpire

HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression

  • By

  • Juan Wang

  • Kang Wang

  • Zhenhong Hu

  • Xueting Hu

  • May 25, 2026

  • 0 min

Share

Original Source(s)

HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression

  • by Juan Wang, Kang Wang, Zhenhong Hu, Xueting Hu

  • May 25, 2026

Related Content

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients

Efficacy of IoT-based perioperative respiratory rehabilitation for lung resection: Protocol of a randomized controlled trial

Multiple ground-glass nodules after lobectomy for multiple primary lung cancer: a case report